A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer

Por Zhu, Andrew X., Finn, Richard S., Mulcahy, Mary, Gurtler, Jayne, Sun, Weijing, Schwartz, Jonathan D., Dalal, Rita P., Joshi, Adarsh, Hozak, Rebecca R., Xu, Yihuan, Ancukiewicz, Marek, Jain, Rakesh K., Nugent, Francis W., Duda, Dan G., Stuart, Keith
Publicado no Clin Cancer Res (2013)

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer

Por Vahdat, Linda T., Layman, Rachel, Yardley, Denise A., Gradishar, William, Salkeni, Mohamad A., Joy, Anil Abraham, Garcia, Agustin A., Ward, Patrick, Khatcheressian, James, Sparano, Joseph, Rodriguez, Gladys, Tang, Shande, Gao, Ling, Dalal, Rita P., Kauh, John, Miller, Kathy
Publicado no Oncologist (2017)